IRIS CF assists with sale of Soapoli-online to Preventx

Preventx Limited, a portfolio company of Synova Capital, has acquired 100% of the shares in (SPO). IRIS CF advised the sellers in this transaction during the transaction process. 


SPO is a leading player in the field of online sales of STD tests. Through its web shop, SPO offers a complete range of laboratory tests. In recent years, the company experienced rapid growth, partly because the market for STD tests is moving towards the online segment. Together with Prevenx, SPO will further expand its position in the Dutch market and continue its overall expansion plans.  

For more information, please see:


With its own laboratories in England, Preventx is a leader in the field of integrated testing services. The company has set itself the goal of making sexual health easier, more accessible and more cost-effective. Through collaborations with the National Health Services (NHS) and various local authorities, Preventx has over 87% coverage in England. Services are offered at, and among others.

For more information, please visit: